Sylvie Bonvalot, PhD

Disclosure:
No relationships to disclose.

Presentation(s):

• LBA7 - Act.in.Sarc: An International Randomized Phase III Trial Evaluating Efficacy and Safety of First-in-Class NBTXR3 Hafnium Oxide Nanoparticles Activated By Preoperative Radiotherapy in Locally Advanced Soft Tissue Sarcoma

  Tuesday, October 23
  8:35 AM – 8:45 AM